PrOMOTE for Smoking, Cigarette

Phase-Based Progress Estimates
Medical University of South Carolina, Charleston, SC
Smoking, Cigarette+1 More
PrOMOTE - Behavioral
All Sexes
Eligible conditions

Study Summary

Optimizing Tobacco Treatment Delivery for People Living With HIV

See full description

Eligible Conditions

  • Smoking, Cigarette
  • Hiv

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Smoking, Cigarette

Study Objectives

This trial is evaluating whether PrOMOTE will improve 1 primary outcome and 4 secondary outcomes in patients with Smoking, Cigarette. Measurement will happen over the course of 7 days.

24 weeks (study completion)
Acceptability of intervention
Fidelity of intervention
Perceived barriers to the outcomes
7 days
Tobacco use abstinence

Trial Safety

Safety Progress

1 of 3

Other trials for Smoking, Cigarette

Trial Design

2 Treatment Groups

Treatment as Usual
1 of 2
1 of 2
Active Control
Experimental Treatment

This trial requires 231 total participants across 2 different treatment groups

This trial involves 2 different treatments. PrOMOTE is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

In the PrOMOTE group, the participants will be contacted by the clinical pharmacist on the tobacco treatment staff three times for medication prescriptions and refills. They will also receive brief counseling and motivational interviewing by the clinical pharmacist.
Treatment as UsualTreatment as Usual (TAU) participants will follow traditional clinic pathways for receiving tobacco treatment in the Medical University of South Carolina Health Infectious Disease outpatient clinic. All patients randomized to TAU will have the opportunity to access smoking cessation pharmacotherapy from the Infectious Disease clinical pharmacist.

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 24 weeks (study completion)
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly 24 weeks (study completion) for reporting.

Who is running the study

Principal Investigator
A. R.
Prof. Alana Rojewski, Assistant Professor
Medical University of South Carolina

Closest Location

Medical University of South Carolina - Charleston, SC

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. There are 5 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
Age 21 and older
/AIDS The current diagnosis of HIV/AIDS is done through a process of elimination show original
A person who currently smokes, regardless of how much they smoke. show original
Some people are willing to be randomized in order to receive a treatment they believe may be effective show original
English speaking

Patient Q&A Section

What are common treatments for hiv?

"HIV does not cure, and most patients will remain at high risk for development of HIV-related complications over the course of their life. HIV care is typically delivered as a part of a team by a specialist, specifically a general practitioner (GP), nurse, family doctor, psychiatrist, or psychiatrist with a specialist background, such as a psychiatrist or psychologist.\n" - Anonymous Online Contributor

Unverified Answer

What are the signs of hiv?

"The presence of symptoms, such as low CD4 count and viral loads, can indicate the presence of hiv. There are no specific symptoms of hiv. There is also no general medical symptom that can be used to diagnose hiv. Treatment of hiv can include HAART, but it can also include antiviral therapy.\n" - Anonymous Online Contributor

Unverified Answer

What causes hiv?

"HIV can be prevented through abstinence or limiting exposure to infected partners. HIV infection results from exposure to an infected person. The incubation period varies, from several months to years, depending on the stage of viral load, the strain of virus, the immune status of the infected person and the health of surrounding people.\n" - Anonymous Online Contributor

Unverified Answer

What is hiv?

"HIV is an infectious disease that can spread from one individual to another through sexual contact or with contaminated needles or blood. HIV mostly affects HIV+ individuals and is spread through bodily fluids or via sexual contact. HIV is a chronic condition with an incubation period of up to 35 years." - Anonymous Online Contributor

Unverified Answer

How many people get hiv a year in the United States?

"About 2 and 1/3 of Americans may have had sex with a sex worker or with a person who has an undetectable viral load; only 1/2 of those may have had sex with a sex worker or with a person who has an undetectable viral load. The HIV prevalence among sex workers and drug users is likely to be higher than among the general population. The HIV test and counseling and prevention services available to the general population may not target people at increased risk of HIV infection." - Anonymous Online Contributor

Unverified Answer

Can hiv be cured?

"Once a person has contracted HIV, it is highly unlikely that the virus can be totally 'cured', so that a cure is not possible. However those infected with HIV who are treated to an undetectable HIV level and manage other co-existing diseases can live a long and healthy life, particularly if the HIV infection is under control." - Anonymous Online Contributor

Unverified Answer

Have there been other clinical trials involving promote?

"There are a larger number of clinical trials concerning promote than concerning medication to treat HIV-1. Some clinical trials involve only one method but most of clinical trials encompass more than one method." - Anonymous Online Contributor

Unverified Answer

Does promote improve quality of life for those with hiv?

"Results from a recent clinical trial add to the literature showing that psychological and social well-being, not just QoL is improved with HIV treatment intervention, and support the need for ongoing intervention strategies in order to continue to improve QoL throughout HIV trajectory including beyond the first year post diagnosis." - Anonymous Online Contributor

Unverified Answer

How does promote work?

"Support from health workers as well as the general community could be an essential tool in the success of the ART/HAART programme. Initiatives to improve support in the health facility could be successful as shown by the example of South Africa’s MOH and SAPS where it was successful in increasing numbers of ART users." - Anonymous Online Contributor

Unverified Answer

What are the latest developments in promote for therapeutic use?

"There are certain barriers that limit therapeutic use. Barriers that are often overlooked are cost, lack of access to proper health care, and not knowing the benefits of treatment. Many of these barriers can be relieved by incorporating social factors into our health care system." - Anonymous Online Contributor

Unverified Answer

What is the average age someone gets hiv?

"About a quarter of adults in the United States are infected with HIV. People may develop HIV from a partner's current infection as early as 9 years of age and on average from 20 to 28 years of age." - Anonymous Online Contributor

Unverified Answer

How serious can hiv be?

"HIV is an infection (and, in principle, a potentially fatal one) which may be successfully diagnosed, treated and prevented if appropriate strategies are used. Current preventive measures rely on education programs and condom use. However, in many developing countries preventive techniques for HIV are either unavailable or inadequately implemented. Although the benefits of prevention include the avoidance of AIDS-related diseases and death, there is little convincing evidence that the impact of these programmes exceeds the costs. It is argued that health professionals play a key role in making effective use of preventive services." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
See if you qualify for this trial
Get access to this novel treatment for Smoking, Cigarette by sharing your contact details with the study coordinator.